The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer
Richard J Rebello, Eric Kusnadi, Donald P Cameron, Helen B Pearson, Analia Lesmana, Jennifer R Devlin, Denis Drygin, Ashlee K Clark, Laura Porter, John Pedersen, Shahneen Sandhu, Gail P Risbridger, Richard B Pearson, Ross D Hannan, Luc Furic
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2016
Related Projects (2)
Awarded by Cancer Australia
Awarded by Prostate Cancer Foundation of Australia
Awarded by National Health and Medical Research Council
This work was supported by Cancer Australia (CA 1084546 to R.D. Hannan, R.B. Pearson, G.P. Risbridger, and L. Furic); Prostate Cancer Foundation of Australia (YI 0310 to L. Furic and CG 1511 to R.B. Pearson, R.D. Hannan, and L. Furic and YIA to S. Sandhu); National Health and Medical Research Council (Program Grant 1053792 and Project Grant 1004881 to R.B. Pearson and R.D. Hannan; Senior Research Fellowships to R.B. Pearson and R.D. Hannan and Senior Principal Research Fellowship APP1102752 to G.P. Risbridger).